Balance Sheet Marinus Pharmaceuticals, Inc.

Equities

MRNS

US56854Q2003

Pharmaceuticals

Market Closed - Nasdaq Other stock markets 04:00:00 2024-09-13 pm EDT			5-day change	1st Jan Change
1.500 ^USD	+7.91%		+7.14%	-86.20%

Aug. 14	Ladenburg Thalmann Downgrades Marinus Pharmaceuticals to Neutral From Buy	MT
Aug. 13	Transcript : Marinus Pharmaceuticals, Inc., Q2 2024 Earnings Call, Aug 13, 2024

5328cae8fbde54e.bpe6wekBdB5TOzji4Yt5t4dBCvGJbpLFMD1RPBoL2jk.G_zRiJpWLGlkD27PrPEJ4N12b7XgWdmiVXYXaShev3cj0dj5gXEDemZqYQ

Published financial data: MARINUS PHARMACEUTICALS, INC.

Annual

Quarterly

Halfyear

YTD

LTM

Fiscal Period: December	2019	2020	2021	2022	2023
Revenues	-	1.72M	15.34M	25.48M	30.99M
Total Revenues	-	1.72M	15.34M	25.48M	30.99M
Cost of Goods Sold, Total	-	50.51M	74.4M	81.42M	101M
Gross Profit	-	-48.79M	-59.05M	-55.94M	-70.33M
Selling General & Admin Expenses, Total	10.86M	19.15M	35.78M	56.84M	61.15M
R&D Expenses	42.27M	-	-	-	-
Other Operating Expenses, Total	53.12M	19.15M	35.78M	56.84M	61.15M
Operating Income	-53.12M	-67.94M	-94.83M	-113M	-131M
Interest Expense, Total	-	-	-2.58M	-10.67M	-16.9M
Interest And Investment Income	354K	499K	80K	2.35M	8.11M
Net Interest Expenses	354K	499K	-2.5M	-8.32M	-8.78M
Other Non Operating Income (Expenses)	-53K	-37K	900K	-1.87M	1.38M
EBT, Excl. Unusual Items	-52.82M	-67.48M	-96.43M	-123M	-139M
Gain (Loss) On Sale Of Assets	-	-	-	107M	-4M
Asset Writedown	-	-	-243K	-828K	-61K
Other Unusual Items	-1.3M	-	-2.1M	-	-
EBT, Incl. Unusual Items	-54.12M	-67.48M	-98.78M	-16.43M	-143M
Income Tax Expense	-	-	-	3.39M	-1.54M
Earnings From Continuing Operations	-54.12M	-67.48M	-98.78M	-19.82M	-141M
Net Income to Company	-54.12M	-67.48M	-98.78M	-19.82M	-141M
Net Income - (IS)	-54.12M	-67.48M	-98.78M	-19.82M	-141M
Preferred Dividend and Other Adjustments	-	8.88M	-	-	-
Net Income to Common Incl Extra Items	-54.12M	-76.36M	-98.78M	-19.82M	-141M
Net Income to Common Excl. Extra Items	-54.12M	-76.36M	-98.78M	-19.82M	-141M
Per Share Items
Net EPS - Basic	-3.97	-2.8	-2.69	-0.51	-2.63
Basic EPS - Continuing Operations	-3.97	-2.8	-2.69	-0.51	-2.63
Basic Weighted Average Shares Outstanding	13.63M	27.27M	36.7M	39.07M	53.75M
Net EPS - Diluted	-3.97	-2.8	-2.69	-0.51	-2.63
Diluted EPS - Continuing Operations	-3.97	-2.8	-2.69	-0.51	-2.63
Diluted Weighted Average Shares Outstanding	13.63M	27.27M	36.7M	39.07M	53.75M
Normalized Basic EPS	-2.42	-1.55	-1.64	-1.97	-1.62
Normalized Diluted EPS	-2.42	-1.55	-1.64	-1.97	-1.62
Supplemental Items
EBITDA	-52.84M	-67.6M	-94.48M	-111M	-126M
EBITA	-53.12M	-67.94M	-94.83M	-112M	-127M
EBIT	-53.12M	-67.94M	-94.83M	-113M	-131M
EBITDAR	-52.14M	-67M	-93.88M	-111M	-126M
Total Revenues (As Reported)	-	-	15.34M	25.48M	30.99M
Effective Tax Rate - (Ratio)	-	-	-	-20.63	1.08
Normalized Net Income	-33.01M	-42.17M	-60.27M	-76.86M	-86.8M
Interest on Long-Term Debt	-	-	2.58M	10.67M	16.9M
Supplemental Operating Expense Items
General and Administrative Expenses	10.16M	18.55M	35.18M	-	-
Research And Development Expense From Footnotes	42.97M	51.11M	75M	80.06M	99.41M
Net Rental Expense, Total	700K	600K	600K	600K	600K
Imputed Operating Lease Interest Expense	-	-	534K	696K	757K
Imputed Operating Lease Depreciation	-	-	65.66K	-95.92K	-157K
Stock-Based Comp., COGS (Total)	-	2.94M	4.48M	5.36M	5.81M
Stock-Based Comp., R&D Exp. (Total)	2.58M	-	-	-	-
Stock-Based Comp., G&A Exp. (Total)	3.09M	4.7M	9.38M	-	-
Stock-Based Comp., SG&A Exp. (Total)	-	-	-	9.53M	9.76M
Total Stock-Based Compensation	5.67M	7.64M	13.87M	14.89M	15.56M

Fiscal Period: December	2019	2020	2021	2022	2023
Assets
Cash And Equivalents	90.94M	139M	123M	241M	121M
Short Term Investments	739K	1.47M	-	-	29.72M
Total Cash And Short Term Investments	91.68M	140M	123M	241M	150M
Accounts Receivable, Total	-	1.65M	3.19M	6.35M	3.8M
Total Receivables	-	1.65M	3.19M	6.35M	3.8M
Inventory	-	-	-	77K	2.41M
Prepaid Expenses	2.45M	4.64M	5.56M	5.4M	8.75M
Other Current Assets, Total	-	-	-	-	-
Total Current Assets	94.13M	146M	132M	252M	165M
Gross Property Plant And Equipment	5.28M	5.08M	5.59M	6.99M	6.74M
Accumulated Depreciation	-812K	-1.13M	-1.39M	-1.45M	-1.9M
Net Property Plant And Equipment	4.46M	3.94M	4.2M	5.54M	4.84M
Long-term Investments	-	-	-	-	-
Other Long-Term Assets, Total	243K	250K	963K	1.6M	819K
Total Assets	98.84M	150M	137M	260M	171M
Liabilities
Accounts Payable, Total	2.76M	2.21M	3.13M	4.46M	4M
Accrued Expenses, Total	4.82M	8.01M	15.65M	16.45M	22.08M
Current Portion of Long-Term Debt	-	-	-	1.02M	13.76M
Current Portion of Leases	446K	510K	556K	637K	774K
Current Income Taxes Payable	-	-	-	2.44M	-
Other Current Liabilities	-	-	21.23M	-	-
Total Current Liabilities	8.03M	10.73M	40.57M	25.02M	40.62M
Long-Term Debt	-	-	40.81M	101M	95.19M
Long-Term Leases	3.04M	2.53M	1.98M	1.34M	633K
Unearned Revenue Non Current	-	-	-	16.28M	17.54M
Other Non Current Liabilities	-	-	-	-	152K
Total Liabilities	11.07M	13.26M	83.35M	144M	154M
Preferred Stock Convertible	28.2M	4.47M	4.3M	4.04M	-
Total Preferred Equity	28.2M	4.47M	4.3M	4.04M	-
Common Stock, Total	87K	37K	37K	50K	55K
Additional Paid In Capital	295M	445M	460M	542M	589M
Retained Earnings	-236M	-312M	-411M	-431M	-572M
Comprehensive Income and Other	-	-	-	-	-20K
Total Common Equity	59.57M	133M	49.18M	112M	16.76M
Total Equity	87.77M	137M	53.49M	116M	16.76M
Total Liabilities And Equity	98.84M	150M	137M	260M	171M
Supplemental Items
ECS Total Shares Outstanding on Filing Date	21.68M	36.58M	37M	49.67M	54.64M
ECS Total Common Shares Outstanding	21.62M	36.58M	36.79M	49.64M	54.58M
Book Value / Share	2.76	3.63	1.34	2.26	0.31
Tangible Book Value	59.57M	133M	49.18M	112M	16.76M
Tangible Book Value Per Share	2.76	3.63	1.34	2.26	0.31
Total Debt	3.49M	3.04M	43.34M	104M	110M
Net Debt	-88.19M	-137M	-79.58M	-137M	-39.93M
Debt Equivalent Oper. Leases	5.6M	4.8M	4.8M	4.8M	4.8M
Account Code - Inventory Valuation	3	3	3	3	3
Machinery, Total	2.18M	2.18M	2.99M	4.79M	4.84M
Full Time Employees	40	65	113	151	165
Part Time Employees	3	7	-	2	1

Fiscal Period: December	2019	2020	2021	2022	2023
Net Income	-54.12M	-67.48M	-98.78M	-19.82M	-141M
Depreciation & Amortization - CF	278K	334K	355K	418K	551K
Amortization of Goodwill and Intangible Assets - (CF)	-	-	-	956K	4.81M
Depreciation & Amortization, Total	278K	334K	355K	1.37M	5.36M
Amortization of Deferred Charges, Total - (CF)	-	-	549K	1.66M	2.25M
(Gain) Loss From Sale Of Asset	42K	-	243K	-107M	-
(Gain) Loss on Sale of Investments - (CF)	-8K	3K	-	-	-1.24M
Asset Writedown & Restructuring Costs	-	-	-	828K	61K
Stock-Based Compensation (CF)	5.67M	7.64M	13.87M	16.06M	15.56M
Other Operating Activities, Total	94K	626K	-414K	473K	-753K
Change In Accounts Receivable	-	-	-452K	17.89M	2.61M
Change In Accounts Payable	890K	1.88M	7.84M	3.75M	2.11M
Change in Other Net Operating Assets	-1.48M	-3.92M	21.31M	-27.74M	-2.55M
Cash from Operations	-48.63M	-60.91M	-55.48M	-113M	-118M
Capital Expenditure	-388K	-	-2.89M	-1.77M	-119K
Sale of Property, Plant, and Equipment	-	-	-	108M	9K
Investment in Marketable and Equity Securities, Total	4.27M	-738K	1.47M	-	-28.5M
Cash from Investing	3.88M	-738K	-1.42M	106M	-28.6M
Short Term Debt Issued, Total	-	-	-	-	-
Long-Term Debt Issued, Total	-	-	40.26M	58.51M	-
Total Debt Issued	-	-	40.26M	58.51M	-
Short Term Debt Repaid, Total	-	-	-	-	-
Long-Term Debt Repaid, Total	-	-	-	-42K	-
Total Debt Repaid	-	-	-	-42K	-
Issuance of Common Stock	67.97M	109M	1.2M	66.27M	26.63M
Other Financing Activities, Total	-	-	-148K	-	-
Cash from Financing	67.97M	109M	41.31M	125M	26.63M
Net Change in Cash	23.22M	47.57M	-15.58M	118M	-120M
Supplemental Items
Cash Interest Paid	-	-	-	7.89M	8.7M
Cash Income Tax Paid (Refund)	-	-	-	-	903K
Levered Free Cash Flow	-28.2M	-35.68M	-21.68M	-80.74M	-70.09M
Unlevered Free Cash Flow	-28.2M	-35.68M	-20.61M	-75.73M	-61.78M
Change In Net Working Capital	561K	1.2M	-27.32M	19.73M	403K
Net Debt Issued / Repaid	-	-	40.26M	58.47M	-

Fiscal Period: December	2019	2020	2021	2022	2023
Profitability
Return on Assets	-38.15	-34.06	-41.26	-35.57	-38.18
Return on Total Capital	-41.61	-36.68	-50	-44.52	-47.37
Return On Equity %	-69.34	-59.99	-103.6	-23.38	-213.02
Return on Common Equity	-84.63	-79.41	-108.6	-24.59	-219.71
Margin Analysis
Gross Profit Margin %	-	-2.84K	-384.84	-219.57	-226.96
SG&A Margin	-	1.11K	233.16	223.11	197.33
EBITDA Margin %	-	-3.93K	-615.68	-437.29	-407.01
EBITA Margin %	-	-3.95K	-617.99	-438.94	-408.79
EBIT Margin %	-	-3.95K	-617.99	-442.69	-424.3
Income From Continuing Operations Margin %	-	-3.93K	-643.7	-77.78	-456.31
Net Income Margin %	-	-3.93K	-643.7	-77.78	-456.31
Net Avail. For Common Margin %	-	-4.44K	-643.7	-77.78	-456.31
Normalized Net Income Margin	-	-2.45K	-392.77	-301.67	-280.1
Levered Free Cash Flow Margin	-	-2.08K	-141.26	-316.88	-226.18
Unlevered Free Cash Flow Margin	-	-2.08K	-134.33	-297.23	-199.36
Asset Turnover
Asset Turnover	-	0.01	0.11	0.13	0.14
Fixed Assets Turnover	-	0.41	3.77	5.23	5.97
Receivables Turnover (Average Receivables)	-	-	6.35	5.34	6.11
Inventory Turnover (Average Inventory)	-	-	-	-	81.38
Short Term Liquidity
Current Ratio	11.72	13.63	3.25	10.09	4.07
Quick Ratio	11.42	13.2	3.11	9.87	3.79
Operating Cash Flow to Current Liabilities	-6.06	-5.68	-1.37	-4.51	-2.9
Days Sales Outstanding (Average Receivables)	-	-	57.47	68.29	59.76
Days Outstanding Inventory (Average Inventory)	-	-	-	-	4.48
Average Days Payable Outstanding	-	18.02	13.09	-	14.9
Cash Conversion Cycle (Average Days)	-	-	-	-	49.34
Long Term Solvency
Total Debt/Equity	3.97	2.22	81.04	89.55	658.26
Total Debt / Total Capital	3.82	2.17	44.76	47.24	86.81
LT Debt/Equity	3.47	1.85	80	88.12	571.56
Long-Term Debt / Total Capital	3.33	1.81	44.19	46.49	75.38
Total Liabilities / Total Assets	11.2	8.81	60.91	55.3	90.19
EBIT / Interest Expense	-	-	-36.73	-10.57	-7.78
EBITDA / Interest Expense	-	-	-36.36	-10.38	-7.43
(EBITDA - Capex) / Interest Expense	-	-	-37.48	-10.55	-7.44
Total Debt / EBITDA	-0.07	-0.05	-0.46	-0.94	-0.88
Net Debt / EBITDA	1.69	2.04	0.85	1.23	0.32
Total Debt / (EBITDA - Capex)	-0.07	-0.05	-0.45	-0.92	-0.88
Net Debt / (EBITDA - Capex)	1.68	2.04	0.82	1.21	0.32
Growth Over Prior Year
Total Revenues, 1 Yr. Growth %	-	-	793.19	66.03	21.63
Gross Profit, 1 Yr. Growth %	-	15.43	21.04	-6.22	25.72
EBITDA, 1 Yr. Growth %	42.62	24.86	39.75	15.36	13.21
EBITA, 1 Yr. Growth %	42.88	24.83	39.59	15.37	13.28
EBIT, 1 Yr. Growth %	42.88	24.83	39.59	16.36	16.58
Earnings From Cont. Operations, 1 Yr. Growth %	47.36	24.67	46.39	-79.94	613.59
Net Income, 1 Yr. Growth %	47.36	24.67	46.39	-79.94	613.59
Normalized Net Income, 1 Yr. Growth %	43.82	24.67	42.92	24.8	12.94
Diluted EPS Before Extra, 1 Yr. Growth %	10.55	-29.49	-3.87	-81.05	418.77
Accounts Receivable, 1 Yr. Growth %	-	-	93.56	99.25	-40.15
Inventory, 1 Yr. Growth %	-	-	-	-	3.03K
Net Property, Plant and Equip., 1 Yr. Growth %	245.05	-11.65	6.44	31.84	-12.52
Total Assets, 1 Yr. Growth %	31.38	52.22	-9.05	89.65	-34.14
Tangible Book Value, 1 Yr. Growth %